Search

Aim: To investigate the efficacy of intra-ruminal Zn boluses as aids in providing protection from natural Pithomyces chartarum challenge in calves., Methods: Sixty-two calves (mean weight 187 (SEM 3.25) kg) were divided into three groups. Commencing on Day 0, they received either a proprietary bolus containing 83% ZnO (ZnO group), a prototype Zn bolus containing 88% elemental Zn (Zn group), or remained untreated (Control group). Concentrations of Zn in serum and faeces were measured weekly between Days 6 and 34, activities of gamma-glutamyl transferase (GGT) in serum on Days -8, 20, 34 and 41, and faecal spore counts between Days 13 and 41., Results: Between Days 6 and 34, mean concentrations of Zn in serum increased in both Zn treatment groups compared with Controls (p<0.001), but were lower in Zn than ZnO animals between Days 6 and 28 (p=0.05). Concentrations of Zn in faeces were increased in both groups following treatment with Zn. Mean concentrations of Zn in faeces in ZnO animals was higher than Zn animals on Days 13 and 20 (p<0.001), but decreased by Day 34, whereas for Zn animals they were still elevated on Day 34. Faecal spore counts were 354,000 and 183,000 on Days 13 and 20, respectively, 610,500 on Day 28, and 115,500 spores/g on Day 34. There were no clinical signs of facial eczema, but based on the activities of GGT on Day 41, 17/20 (85%) Controls were moderately or severely affected (GGT >250 IU/L) compared with 1/21 (5%) ZnO and 3/21 (14%) Zn animals. Mean activities of GGT on Day 41 for ZnO and Zn animals were not different (35 (95% CI=23-54) and 54 (95% CI=32-92) IU/L, respectively; p=0.18), but were below those of the Controls (502 (95% CI=296-850) IU/L), confirming efficacy of both bolus treatments. In both ZnO and Zn animals, there was no significant relationship between concentration of Zn in serum and activity of GGT, but in Zn animals there was a significant relationship between the concentration of Zn in faeces and activity of GGT 21 days later. The regression equation y=2.136-0.002197x (where y is log10GGT activity, and x the concentration of Zn in faeces) provided an estimate of the threshold level of concentration of Zn in faeces., Conclusion: The study confirmed efficacy of elemental Zn boluses in providing protection from natural P. chartarum challenge in young cattle.

Aim: To investigate the efficacy of intra-ruminal Zn boluses as aids in providing protection from natural Pithomyces chartarum challenge in sheep., Methods: Seventy-two adult sheep (mean weight 59 (SEM 0.5) kg) were divided into four groups. Commencing on Day 0, they received either a proprietary bolus containing 67 g ZnO (equivalent to 54 g Zn) (ZnO group), two different levels of elemental Zn (81 and 108 g) delivered in boluses each containing 27 g Zn (Zn81 and Zn108 groups, respectively), or remained untreated (control). Concentrations of Zn in serum, activities of gamma-glutamyl transferase (GGT) in serum, and spore counts on pasture were measured weekly from Day -6, and concentrations of Zn in faeces weekly from Day 21, until Day 77., Results: Mean concentrations of Zn in serum between Days 14 and 42 were significantly higher in ZnO animals (15.4 (SEM 0.70) micromol/L) than the other groups. Mean concentrations in Zn108 animals (11.1 (SEM 0.26) micromol/L) were significantly higher than controls, but there were no differences between Zn81 and the controls (9.9 (SEM 0.20) and 9.4 (SEM 0.26) micromol/L, respectively). Between Days 21 and 49, there was no significant difference in mean concentrations of Zn in faeces between ZnO and Zn81 animals (307 (SEM 28) and 281 (SEM 29) mg/kg fresh weight (FW), respectively), but concentrations were significantly higher in Zn108 animals (500 (SEM 40) mg/kg FW). Spore counts exceeded 70,000/g on Days 14, 28, 49, 56 and 63 but there were no clinical signs of facial eczema. In controls, activities of GGT were unchanged until Day 21, then increased to 637 IU/L at Day 70; for ZnO animals, activities remained <75 IU/L until Day 14, then increased to 200 IU/L at Day 70; for Zn81 and Zn108, they remained <75 IU/L until Day 35, and then increased at Day 70 to 369 IU/L and 293 IU/L, respectively. From Day 56 activities were significantly lower in all treated groups compared with controls, but there was no significant difference between the three Zn bolus treatments. There were significant negative correlations between activities of GGT and concentrations of Zn in serum in Zn108 animals, and with concentrations of Zn in faeces for both Zn81 and Zn108 groups., Conclusion: Elemental Zn boluses can reduce activities of GGT associated with elevated spore counts. The association between concentrations of Zn in faeces and activities of GGT suggests that a minimum concentration of Zn in the gastrointestinal tract may be important in providing protection against sporidesmin.